Shared Decision Making Aid for Thyroid Cancer
Trial Summary
What is the purpose of this trial?
There is an epidemic of thyroid cancer that is harmful to patients and the medical system. The study hypothesizes that the use of an electronic conversation aid during clinical visits can help patients and clinicians collaborate when deciding the next step in management for a thyroid nodule. The study aims to update a conversation aid prototype that was developed to support shared decision making in the diagnosis of thyroid cancer. This entry (Aim 1) has an associated study (Aim 2) registered under NCT04463719
Research Team
Naykky Singh Ospina
Principal Investigator
University of Florida
Eligibility Criteria
This trial is for adults over 18 years old who are being evaluated for a thyroid nodule. It's not open to pregnant individuals, prisoners, those with an overactive thyroid (hyperthyroidism), or anyone who has already had a biopsy of the nodule in question.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Counseling using the electronic conversation aid (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Florida
Lead Sponsor
Dr. Stephen J. Motew
University of Florida
Chief Executive Officer since 2024
MD cum laude from the University of Illinois at Chicago School of Medicine, Master's in Healthcare Administration from the University of North Carolina at Chapel Hill
Dr. Timothy E. Morey
University of Florida
Chief Medical Officer since 2023
MD and Bachelor's from the University of Florida
National Cancer Institute (NCI)
Collaborator
Dr. Douglas R. Lowy
National Cancer Institute (NCI)
Chief Executive Officer since 2023
MD from New York University School of Medicine
Dr. Monica Bertagnolli
National Cancer Institute (NCI)
Chief Medical Officer since 2022
MD from Harvard Medical School